FBIO
Fortress Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.72
+0.37%Margins
Gross margin
62.5%
EBITDA margin
233.4%
EBIT margin
-42.9%
Net margin
163.3%
FCF margin
183.8%
68.1%
Return on equity
35.3%
Return on assets
-12.8%
Return on invested capital
0.20x
Asset turnover
$125.9M
Cash from operations
$5.89
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026